| Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis F Ceban, S Ling, LMW Lui, Y Lee, H Gill, KM Teopiz, NB Rodrigues, ... Brain, behavior, and immunity 101, 93-135, 2022 | 984 | 2022 |
| Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: an international expert opinion on the available evidence and implementation RS McIntyre, JD Rosenblat, CB Nemeroff, G Sanacora, JW Murrough, ... American Journal of Psychiatry 178 (5), 383-399, 2021 | 397 | 2021 |
| Stress, epigenetics and depression: a systematic review C Park, JD Rosenblat, E Brietzke, Z Pan, Y Lee, B Cao, H Zuckerman, ... Neuroscience & Biobehavioral Reviews 102, 139-152, 2019 | 386 | 2019 |
| The interface of depression and obesity N Jantaratnotai, K Mosikanon, Y Lee, RS McIntyre Obesity research & clinical practice 11 (1), 1-10, 2017 | 329 | 2017 |
| Onset and frequency of depression in post-COVID-19 syndrome: A systematic review O Renaud-Charest, LMW Lui, S Eskander, F Ceban, R Ho, ... Journal of psychiatric research 144, 129-137, 2021 | 292 | 2021 |
| The effect of loneliness on distinct health outcomes: a comprehensive review and meta-analysis C Park, A Majeed, H Gill, J Tamura, RC Ho, RB Mansur, F Nasri, Y Lee, ... Psychiatry Research 294, 113514, 2020 | 278 | 2020 |
| Projected increases in suicide in Canada as a consequence of COVID-19 RS McIntyre, Y Lee Psychiatry research 290, 113104, 2020 | 253 | 2020 |
| Applications of machine learning algorithms to predict therapeutic outcomes in depression: a meta-analysis and systematic review Y Lee, RM Ragguett, RB Mansur, JJ Boutilier, JD Rosenblat, A Trevizol, ... Journal of affective disorders 241, 519-532, 2018 | 253 | 2018 |
| The relationship between smartphone addiction and symptoms of depression, anxiety, and attention-deficit/hyperactivity in South Korean adolescents SG Kim, J Park, HT Kim, Z Pan, Y Lee, RS McIntyre Annals of general psychiatry 18, 1-8, 2019 | 244 | 2019 |
| Government response moderates the mental health impact of COVID-19: a systematic review and meta-analysis of depression outcomes across countries Y Lee, LMW Lui, D Chen-Li, Y Liao, RB Mansur, E Brietzke, JD Rosenblat, ... Journal of affective disorders 290, 364-377, 2021 | 205 | 2021 |
| Preventing suicide in the context of the COVID‐19 pandemic RS McIntyre, Y Lee World psychiatry 19 (2), 250, 2020 | 196 | 2020 |
| Association between mood disorders and risk of COVID-19 infection, hospitalization, and death: a systematic review and meta-analysis F Ceban, D Nogo, IP Carvalho, Y Lee, F Nasri, J Xiong, LMW Lui, ... JAMA psychiatry 78 (10), 1079-1091, 2021 | 185 | 2021 |
| Cognitive impairment in major depressive disorder Z Pan, C Park, E Brietzke, H Zuckerman, C Rong, RB Mansur, D Fus, ... CNS spectrums 24 (1), 22-29, 2019 | 180 | 2019 |
| The long-term effect of bariatric surgery on depression and anxiety H Gill, S Kang, Y Lee, JD Rosenblat, E Brietzke, H Zuckerman, ... Journal of affective disorders 246, 886-894, 2019 | 179 | 2019 |
| Inflammation as a neurobiological substrate of cognitive impairment in bipolar disorder: evidence, pathophysiology and treatment implications JD Rosenblat, E Brietzke, RB Mansur, NA Maruschak, Y Lee, RS McIntyre Journal of affective disorders 188, 149-159, 2015 | 160 | 2015 |
| Efficacy of adjunctive infliximab vs placebo in the treatment of adults with bipolar I/II depression: a randomized clinical trial RS McIntyre, M Subramaniapillai, Y Lee, Z Pan, NE Carmona, ... JAMA psychiatry 76 (8), 783-790, 2019 | 151 | 2019 |
| The effect of intravenous, intranasal, and oral ketamine in mood disorders: a meta-analysis RS McIntyre, IP Carvalho, LMW Lui, A Majeed, PS Masand, H Gill, ... Journal of affective disorders 276, 576-584, 2020 | 150 | 2020 |
| Cannabidiol in medical marijuana: research vistas and potential opportunities C Rong, Y Lee, NE Carmona, DS Cha, RM Ragguett, JD Rosenblat, ... Pharmacological Research 121, 213-218, 2017 | 150 | 2017 |
| Guidelines for the recognition and management of mixed depression SM Stahl, DA Morrissette, G Faedda, M Fava, JF Goldberg, PE Keck, ... CNS spectrums 22 (2), 203-219, 2017 | 149 | 2017 |
| Does pharmacogenomic testing improve clinical outcomes for major depressive disorder? A systematic review of clinical trials and cost-effectiveness studies JD Rosenblat, Y Lee, RS McIntyre The Journal of clinical psychiatry 78 (6), 14242, 2017 | 142 | 2017 |
Joshua RosenblatUniversity of Toronto在 utoronto.ca 的电子邮件经过验证
Joshua RosenblatUniversity of Toronto在 utoronto.ca 的电子邮件经过验证
Sidney H. KennedyProfessor of Psychiatry, University of Toronto在 uhn.ca 的电子邮件经过验证